<DOC>
	<DOCNO>NCT02084940</DOCNO>
	<brief_summary>PCOS common endocrinopathy affect 5-10 % woman reproductive age characterize hyperandrogenism , chronic anovulation polycystic ovary . This syndrome serious problem IVF since high risk develop ovarian hyperstimulation syndrome ( OHSS ) ovarian stimulation gonadotropin . The introduction GnRH antagonist IVF reduce incidence severe OHSS , still maintain good ovarian response pregnancy rate . Recently , long act GnRH antagonist , Degarelix , introduce prostatic cancer treatment . Furthermore recent paper report use also induction multiple follicular growth program oocyte donation . The aim study evaluate feasibility GnRH antagonist depot use protocol control ovarian hyperstimulation PCOS woman risk develop OHSS IVF cycle .</brief_summary>
	<brief_title>Long Acting GnRH Antagonist PCOS Women Undergoing IVF</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>regular menstrual cycle ( 2639 day ) primary infertility BMI &lt; 30 woman diabetes metabolic disease woman heart disease woman inflammatory autoimmune disease</criteria>
	<gender>Female</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>PCOS</keyword>
	<keyword>OHSS</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>IVF</keyword>
	<keyword>COH</keyword>
</DOC>